Bionexus Gene Lab Corp. (BGLC)
NASDAQ · Basic Materials
Bionexus Gene Lab Corp. Price to FCF Ratio 2021–2026
Price to free cash flow (P/FCF) ratio for Bionexus Gene Lab Corp. (BGLC): market cap divided by trailing twelve-month free cash flow. As of September 30, 2023 it is 280.52.
From: 06/30/2019To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Bionexus Gene Lab Corp. Price to FCF Ratio — FAQ
Bionexus Gene Lab Corp. (BGLC) price to fcf ratio over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGLC's price to fcf ratio history?
The chart and table above show Bionexus Gene Lab Corp.'s price to fcf ratio by year and by quarter, including the growth rate.